| PreMD Inc. is dedicated to saving and improving people’s lives with simple, painless and patient-friendly tests that can detect life-threatening illnesses at an early stage. Our tests do not require any patient preparation or dietary restrictions and can be performed at the point of care, in a laboratory setting and, in some cases, even at home. |
Cardiovascular Assessment
 |
| Our cardiovascular risk assessment technology, PREVU* Skin Sterol Test, assesses a patient’s risk of heart disease by non-invasively measuring the amount of cholesterol in the skin tissues. |
Cancer Screening Tests
|
| PreMD’s non- or minimally-invasive tests for early-stage colorectal, lung and breast cancers detect a cancer-associated sugar in a sample of rectal mucus, sputum and breast nipple aspirate fluid, respectively. Our cancer tests are in development. |
Our Model for Success
|
| PreMD in-licenses proven technologies that target medical conditions where there is a well-defined, urgent need for tests to assess risk or screen for disease.
We then develop and realize the potential of each technology. This includes managing clinical trials, which are largely funded by third parties, obtaining patent protection, and navigating the regulatory process. At the appropriate time, we aim to out-license our technologies to a strategic partner for commercialization.
This cost-effective, low-risk business model creates a substantial platform for profitability as PreMD’s products are commercialized. |
